Author

Yoonjeong Jang

Seoul National UniversityORCID 0000-0003-1922-9246Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:experimental assay· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Akshay SharmaiD· 1 shared Alessandro SerrettiiD· 1 shared Alicia Powers· 1 shared Bernhard Theodor BauneiD· 1 shared Byung-Chul Lee· 1 shared Cathryn M. LewisiD· 1 shared Chiara FabbriiD· 1 shared Chris Wai Hang LoiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Akshay SharmaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintJun 4, 2026

Trans-ancestry genome-wide association meta-analysis of antidepressant response to selective serotonin reuptake inhibitors in clinical studies of depression

Ke Hu, Chris Wai Hang Lo, Swapnil Awasthi…·Cathryn M. Lewis

This study performs a trans-ancestry GWAS of SSRI response in depression, finding suggestive associations and enrichment in serotonergic pathways but no genome-wide significant variants.

DOI 10.64898/2026.06.03.26354703

humanGWAS summary statistics

𝕏 PostBluesky

GenomicsMolecular TherapyPeer-reviewedJul 30, 2024

Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease

Varun Katta, Kiera O’Keefe, Yichao Li…·Shengdar Q. Tsai

This study develops a genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease, showing efficient editing, therapeutic HbF levels, and no off-target effects.

18 citations

humanwhole-genome sequencing

𝕏 PostBluesky